AI Verdict
BSX has stronger fundamentals based on our AI analysis.
ABBV vs BSX Fundamental Comparison
| Metric | ABBV | BSX |
|---|---|---|
| Revenue | $15.0B | $5.2B |
| Net Income | $695.0M | $1.3B |
| Net Margin | 4.6% | 25.8% |
| ROE | N/A | 5.2% |
| ROA | 0.5% | 3.0% |
| Current Ratio | 0.80x | 1.90x |
| Debt/Equity | N/A | 0.42x |
| EPS | $0.39 | $0.90 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs BSX: Frequently Asked Questions
Is ABBV or BSX the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), BSX has stronger fundamentals. ABBV is graded C (78% confidence) while BSX is graded A (77% confidence). This is not investment advice.
How does ABBV compare to BSX fundamentally?
AbbVie Inc. has ROE of N/A vs BOSTON SCIENTIFIC CORP's 5.2%. Net margins are 4.6% vs 25.8% respectively.
Which stock pays higher dividends, ABBV or BSX?
ABBV has a dividend yield of N/A or no dividend while BSX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or BSX for long term?
For long-term investing, consider that ABBV has a C grade with 78% confidence, while BSX has a A grade with 77% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs BSX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs BSX, the AI consensus favors BSX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.